How close are we to detecting any cancer with a blood test? Researchers are exploring both broad multi-cancer tests and targeted approaches for hard-to-detect tumors, but clinical validation is still needed.

https://www.drugdiscoverynews.com/how-close-are-we-to-detecting-any-cancer-with-a-blood-test-17080 “No cancer signal detected.” A man sighs in relief as his phone delivers the result of a single blood test. In February 2026, a Super Bowl advertisement by Hims & Hers promoted Galleri, a blood-based multi-cancer early detection (MCED) test, promising that a single blood draw could screen for more than 50 types of cancer. The idea is undeniably appealing. A simple test that could catch disease early across a wide range of conditions, offering reassurance or a critical head start on treatment.